genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Marburg virus
      Drug Discovery

      First-In-Human Trial of Marburg Vaccine Shows Promising Results

      Infectious Disease Diagnostics

      Exploring Ways to Block Malaria Transmission

      measles virus
      Infectious Diseases

      Collective Measles Virus Mutations Linked to Fatal Encephalitis

      Bioprocessing

      Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

      Blood cells
      Infectious Diseases

      Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      blood cells
      Blood Disorders

      Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Antibodies

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Bioprocessing

      Cell and Gene Therapy Scale-Up Challenges

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home COVID-19 Candidates COVID-19 Front Runner

COVID-19 Front Runner

  • COVID-19 Antibody
  • COVID-19 Antiviral
  • COVID-19 Definitely Maybe
  • COVID-19 Front Runner
  • COVID-19 Keeping an Eye On
  • COVID-19 RNA
  • COVID-19 Too Soon to Tell
  • COVID-19 VAX
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Moderna – mRNA-1283

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Novartis and Molecular Partners – Ensovibep (MP0420) and MP0423

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Bharat Biotech and Ocugen – COVAXIN™

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Gamaleya Research Institute of Epidemiology and Microbiology – Sputnik V

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Eli Lilly, Junshi Biosciences, and Institute of Microbiology, Chinese Academy of Science – etesevimab (LY-CoV016 or JS016)

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Sinopharm Group (China National Biotech Group, Beijing Institute of Biological Products)...

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    AstraZeneca – EVUSHELD™ (AZD7442)

    COVID-19 Front Runner

    Novavax – NVX-CoV2373 (Nuvaxovid™ in Europe and Australia; COVOVAX™ in India...

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Sinovac Biotech – CoronaVac

    COVID-19 Front Runner

    COVID-19 Vaccine AstraZeneca (marketed in some countries as Vaxzevria or Covishield;...

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Merck & Co., Ridgeback Biotherapeutics, and Drug Innovations at Emory (DRIVE)...

    COVID-19 Front Runner

    Regeneron Pharmaceuticals and Roche – REGEN-COV™ / Ronapreve™ (casirivimab and imdevimab)

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    NRx Pharmaceuticals and Relief Therapeutics – Zyesami™ (aviptadil; formerly RLF-100)

    Coronavirus 2019-nCoV spreading
    COVID-19 Front Runner

    Pfizer – PAXLOVID™ (nirmatrelvir; PF-07321332)

    COVID-19 Front Runner

    Eli Lilly and AbCellera – Bamlanivimab (LY-CoV555)

    123Page 1 of 3

    Recently Featured

    Exploring Ways to Block Malaria Transmission

    Exploring Ways to Block Malaria Transmission

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up